Author:
Landewé Robert,Nurminen Tommi,Davies Owen,Baeten Dominique
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Rudwaleit M, Landewé R, van der Heijde D, et al. The development of assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis. 2009;68(6):770–6.
2. Sieper J, van der Heijde D, Elewaut D et al. Disease burden is comparable in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis [abstract]. American College of Rheumatology 2012. November 9–14; Washington, DC. Abstract no. 1361.
3. Baraliakos X, Braun J. Non-radiographic axial spondyloarthritis and ankylosing spondylitis: what are the similarities and differences? RMD Open. 2015;1(Suppl 1):e000053.
4. Sieper J. SP0108 Different approaches to drug approval by EMA and FDA—the example of non-radiographic axial spondyloarthritis. Ann Rheum Dis. 2016;75(Suppl 2):27.
5. U.S. Food and Drug Administration. Center for Drug Evaluation and Research. Cimzia (2008).
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/125160s270lbl.pdf
. Accessed 19 June 2017.
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献